The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens
- PMID: 15256539
- DOI: 10.1124/jpet.104.070235
The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens
Abstract
It has been proposed that nicotine-stimulated locomotor activity (LMA) and nicotine-induced dopamine (DA) release in the mesocorticolimbic DA system is partly regulated by glutamate receptors, particularly N-methyl-D-aspartate (NMDA) receptors. The functional characteristics of NMDA receptors depend on their subunit composition (NR1 in combination with NR2A-D). In the present study, we investigated the effect of the NR2B-selective NMDA receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] on nicotine-stimulated LMA and nicotine-induced DA release in the nucleus accumbens (NAcc) in rats. Ro 25-6981 (3 and 10 mg/kg i.p.) given 10 min prior to a high dose (0.6 mg/kg s.c.) or a subthreshold dose (0.1 mg/kg s.c.) of nicotine potentiated nicotine-stimulated LMA with no effect when administered alone. Similarly, administration of a low dose (0.05 mg/kg i.p.) of the noncompetitive NMDA receptor antagonist MK-801 (dizocilpine maleate) had no effect on LMA by itself but potentiated nicotine-induced (0.1 mg/kg) LMA. However, pretreatment with the competitive NMDA receptor antagonist CGP39551 [(E)-(+/-)-2-amino-4-methyl-5-phosphono-3-pentenoic acid ethyl ester] (10 mg/kg i.p.) did not potentiate the LMA effect of 0.1 mg/kg nicotine as seen with Ro 25-6981. In vivo microdialysis revealed a significant increase of DA release in the NAcc in response to nicotine (0.1 mg/kg s.c.). In analogy to our LMA data, Ro 25-6981 (10 mg/kg i.p.) significantly potentiated the nicotine-induced DA release, although it had no effect on DA release when given alone. The data suggest that, compared with other subunits of the NMDA receptor, the NR2B subunit might play a different role in the reinforcing effects of nicotine.
Similar articles
-
Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551.Psychopharmacology (Berl). 2004 Aug;175(1):114-23. doi: 10.1007/s00213-004-1797-7. Epub 2004 Apr 16. Psychopharmacology (Berl). 2004. PMID: 15088078
-
Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area.J Pharmacol Exp Ther. 2000 Aug;294(2):458-65. J Pharmacol Exp Ther. 2000. PMID: 10900219
-
Role of NR2B-containing N-methyl-D-aspartate receptors in haloperidol-induced c-Fos expression in the striatum and nucleus accumbens.Neuroscience. 2003;122(3):739-45. doi: 10.1016/j.neuroscience.2003.08.019. Neuroscience. 2003. PMID: 14622917
-
N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens.Neuroscience. 1998 Feb;82(3):781-9. doi: 10.1016/s0306-4522(97)00243-1. Neuroscience. 1998. PMID: 9483535
-
NMDA and Dopamine: Diverse Mechanisms Applied to Interacting Receptor Systems.In: Van Dongen AM, editor. Biology of the NMDA Receptor. Boca Raton (FL): CRC Press/Taylor & Francis; 2009. Chapter 3. In: Van Dongen AM, editor. Biology of the NMDA Receptor. Boca Raton (FL): CRC Press/Taylor & Francis; 2009. Chapter 3. PMID: 21204414 Free Books & Documents. Review.
Cited by
-
Relationship of Dopamine of the Nucleus Accumbens with Intra-infralimbic Apomorphine Microinjection.Iran J Basic Med Sci. 2013 Jun;16(6):743-50. Iran J Basic Med Sci. 2013. PMID: 23997899 Free PMC article.
-
Glutamatergic transmission in drug reward: implications for drug addiction.Front Neurosci. 2015 Nov 5;9:404. doi: 10.3389/fnins.2015.00404. eCollection 2015. Front Neurosci. 2015. PMID: 26594139 Free PMC article. Review.
-
The role of P2X7 receptors in a rodent PCP-induced schizophrenia model.Sci Rep. 2016 Nov 8;6:36680. doi: 10.1038/srep36680. Sci Rep. 2016. PMID: 27824163 Free PMC article.
-
Fear memory impairing effects of systemic treatment with the NMDA NR2B subunit antagonist, Ro 25-6981, in mice: attenuation with ageing.Pharmacol Biochem Behav. 2009 Jan;91(3):453-60. doi: 10.1016/j.pbb.2008.08.028. Epub 2008 Sep 8. Pharmacol Biochem Behav. 2009. PMID: 18809426 Free PMC article.
-
Targeting glutamate homeostasis for potential treatment of nicotine dependence.Brain Res Bull. 2016 Mar;121:1-8. doi: 10.1016/j.brainresbull.2015.11.010. Epub 2015 Nov 14. Brain Res Bull. 2016. PMID: 26589642 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials